3-in-1 vax could protect against flu, COVID, and RSV
"We are hopeful that this platform could be expanded further to protect against an even wider range of respiratory viruses in the future."
Read the full articleYou might also wanna read
Study: Three-in-one vaccine shows promise against ‘tripledemic’
University at Buffalo researchers are developing a single shot for flu, COVID-19 and RSV.
The Math Behind RSV Protection: What Expanding Infant Coverage Actually Achieves
A new mathematical model shows that expanding RSV antibody prophylaxis to more infants could prevent infections across all age groups—but wo
CancerVax Develops Novel Smart mRNA to Harness Pre-Existing Immunity in 99% of World Population
Company completes design and in-vitro validation of a single Smart mRNA that disguises cancer as multiple viral infections simultaneously to
Nanoliposome-based subunit vaccine platform targets multiple respiratory viruses simultaneously
Seasonal influenza viruses, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and respiratory syncytial virus (RSV) drive substa
science.org·20d ago
Stanford Researchers Develop Universal Vaccine Formula Protecting Mice Against Respiratory Viruses, Bacteria, and Allergens
Stanford Medicine researchers and their colleagues invented a new vaccine that protects mice from respiratory viruses, bacteria and allergen
med.stanford.edu·4mo agohttps://doi.org/10.1056/NEJMoa2516491
mRNA-1010 flu vax for adults ≥50 boosts safety and efficacy! Phase 3: 37.5μg (12.5μg/strain); promising vs. current shots. Details in NEJM.
Comments
Sign in to join the conversation.
No comments yet. Be the first.